Literature DB >> 3080043

Associated von Willebrand disease as a possible cause of lack of thrombosis in an AT III abnormality (AT III Trento).

A Girolami, M G Cappellato, M A Vicarioto, S Casonato, F Marafioti.   

Abstract

In a family with a known antithrombin III abnormality (AT III Trento) an associated von Willebrand defect (Type I) was found. The two defects seem to segregate independently. In fact four types of individuals were present, namely: subjects with isolated AT III abnormality, subjects with isolated von Willebrand defect, patients with double defect and normal subjects. Only one of the two patients with isolated AT III abnormality showed a thrombotic tendency. None of the patients with double defect showed thrombotic disease, indicating a possible protective action of the von Willebrand defect against thrombotic manifestations. Patients with isolated von Willebrand defect showed neither thrombotic nor bleeding manifestations. The study emphasizes the need for a careful evaluation of the hemostatic balance of patients with AT III abnormalities before concluding that they are symptomatic or asymptomatic.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080043     DOI: 10.1007/bf00320139

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  24 in total

1.  INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.

Authors:  O EGEBERG
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

2.  Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.

Authors:  G Sas; G Blaskó; D Bánhegyi; J Jákó; L A Pálos
Journal:  Thromb Diath Haemorrh       Date:  1974-09-30

3.  Familial thrombosis due to antithrombin 3 deficiency.

Authors:  E Marciniak; C H Farley; P A DeSimone
Journal:  Blood       Date:  1974-02       Impact factor: 22.113

4.  Quantitative immunoelectrophoresis of human serum proteins.

Authors:  H G Clarke; T Freeman
Journal:  Clin Sci       Date:  1968-10       Impact factor: 6.124

5.  Factors influencing thrombosis in familial antithrombin III deficiency.

Authors:  J H Winter; B Bennett
Journal:  Br J Haematol       Date:  1983-03       Impact factor: 6.998

6.  Heparin cofactor activity measured with an amidolytic method.

Authors:  O R Odegard; M Lie; U Abildgaard
Journal:  Thromb Res       Date:  1975-04       Impact factor: 3.944

7.  Abnormal migration of serum antithrombin III in patients on coumarin therapy by cross-immunoelectrophoresis.

Authors:  A Girolami; G M Patrassi; C Vianello; V Pengo
Journal:  Br J Haematol       Date:  1981-11       Impact factor: 6.998

8.  Antifactor Xa activity measured with amidolytic methods.

Authors:  O R Odegård; M Lie; U Abildgaard
Journal:  Haemostasis       Date:  1976

9.  Familial thrombosis: inherited deficiency of antithrombin III.

Authors:  M Mackie; B Bennett; D Ogston; A S Douglas
Journal:  Br Med J       Date:  1978-01-21

10.  A new familial variant of antithrombin III: 'antithrombin III Paris'.

Authors:  M Wolf; C Boyer; J M Lavergne; M J Larrieu
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.